Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialW. Timothy Garvey, Anuj Bhargava, Juan P. Frías et al.|The Lancet|2023Cited by 676
Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults)И. И. Дедов, Valentin V. Fadeyev, Kseniya A. Komshilova et al.|Obesity and metabolism|2018Cited by 167
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"И. И. Дедов, Е. В. Шереметьева, Marina V. Shestakova et al.|Obesity and metabolism|2021Cited by 123
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver DiseaseВ. Т. Ивашкин, Минара Шамхаловна Шамхалова, М. V. Maevskaya et al.|Russian Journal of Gastroenterology Hepatology Coloproctology|2022Cited by 71